Yoav Shmaya

Yoav joined Sight to build and lead its finance team. Prior to joining Sight, Yoav worked at Neuroderm (NASDAQ: NDRM) and had a pivotal role in two follow-on public offerings on Nasdaq and NDRM's acquisition by Mitsubishi Tanabe Pharmaceutical Corporation for $1.1 billion.

As a CPA, Yoav holds a B.A. in Accounting and Economics from Ben Gurion University and currently lectures several courses in the Accounting Department at Ben Gurion University.